Dr. Silvi Rouskin is an assistant professor at the Harvard Medical School. At 16 years old, she enrolled in college at the Florida Institute of Technology, where she obtained a bachelor’s degree in physics. After doing research on detecting new viruses in the lab of Joe DeRisi, she obtained a Ph.D. in biochemistry at the University of California, San Francisco. After obtaining her Ph.D., she started her own research group in the Whitehead Insite for Biomedical Research at MIT. Her lab developed approaches for single-molecule RNA structure probing and identified alternative structures that regulate gene expression of HIV-1. Her achievements were recognized by the 2021 Vilcek Prize for creative promise in biomedical science. Since September 2021, she has been an assistant professor at Harvard Medical School in the
Department of Microbiology, where she continues to study RNA viruses. Her research aims to deepen the understanding of RNA’s roles in critical cellular processes like gene regulation and will pave the way for identifying new RNA-based targets for therapeutic interventions against infections and diseases such as cancer.
Dr. Silvi Rouskin is an assistant professor at the Harvard Medical School. At 16 years old, she enrolled in college at the Florida Institute of Technology, where she obtained a bachelor’s degree in physics. After doing research on detecting new viruses in the lab of Joe DeRisi, she obtained a Ph.D. in biochemistry at the University of California, San Francisco. After obtaining her Ph.D., she started her own research group in the Whitehead Insite for Biomedical Research at MIT. Her lab developed approaches for single-molecule RNA structure probing and identified alternative structures that regulate gene expression of HIV-1. Her achievements were recognized by the 2021 Vilcek Prize for creative promise in biomedical science. Since September 2021, she has been an assistant professor at Harvard Medical School in the
Department of Microbiology, where she continues to study RNA viruses. Her research aims to deepen the understanding of RNA’s roles in critical cellular processes like gene regulation and will pave the way for identifying new RNA-based targets for therapeutic interventions against infections and diseases such as cancer.